what is tirzepatide compounded with Weight Loss Program | GLP-1 Treatment Injectable Tirzepatide | Compounded GLP-1/GIP

These medications mimic the action of the GLP-1 hormone, which is naturally released in the small intestine after meals

Serious adverse events are rare but require medical evaluation

Weight Loss Adherence (12 mo) Total Value Consideration GLP-1 (unmonitored) $10,000$13,000 1015% ~5060% dropout High drug waste GLP-1 (with monitoring) $10,000 + $60 (monitoring) 1015% ~75% persistence ROI-positive (saves $3k+ per patient) SGLT2 inhibitor $6,000$7,000 23% ~70% Lower cost, but modest outcomes Older anti-obesity meds $500$2,000 35% ~4050% Low efficacy, poor tolerability --- 3

Metformin reduces glucose synthesis in the liver, reduces glucose absorption in the intestine, and increases insulin sensitivity by enhancing peripheral glucose uptake and utilization

Over weeks, this pattern can lead to compound nausea and digestive distress